Premier Biomedical, Inc. (BIEI)
OTCMKTS · Delayed Price · Currency is USD
0.0004
0.00 (0.00%)
Mar 9, 2026, 1:52 PM EST
Premier Biomedical Revenue
In the year 2019, Premier Biomedical had annual revenue of $14.28K, down -64.11%. Premier Biomedical had revenue of $1.31K in the quarter ending December 31, 2019, a decrease of -85.63%.
Revenue
14.28K
Revenue Growth
-64.11%
P/S Ratio
44.11
Revenue / Employee
3.57K
Employees
4
Market Cap
629.99K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2019 | 14.28K | -25.51K | -64.11% |
| Dec 31, 2018 | 39.80K | 34.00 | 0.09% |
| Dec 31, 2017 | 39.76K | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Resonate Blends | 2.23M |
| Cannabis Global | 1.06M |
| Nutra Pharma | 392.15K |
| CBD Life Sciences | 178.45K |
| Demand Brands | 165.00K |
| TransGlobal Assets | 91.35K |
| Sky Century Investment | 89.49K |
| Neutra | 66.07K |